Canaan Xi L.p. - Net Worth and Insider Trading

Canaan Xi L.p. Net Worth

The estimated net worth of Canaan Xi L.p. is at least $109 Million dollars as of 2024-11-13. Canaan Xi L.p. is the 10% Owner of Day One Biopharmaceuticals Inc and owns about 6,964,301 shares of Day One Biopharmaceuticals Inc (DAWN) stock worth over $109 Million. Details can be seen in Canaan Xi L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Canaan Xi L.p. has not made any transactions after 2022-09-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Canaan Xi L.p.

To

Canaan Xi L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Canaan Xi L.p. owns 2 companies in total, including Day One Biopharmaceuticals Inc (DAWN) , and Tyra Biosciences Inc (TYRA) .

Click here to see the complete history of Canaan Xi L.p.’s form 4 insider trades.

Insider Ownership Summary of Canaan Xi L.p.

Ticker Comapny Transaction Date Type of Owner
DAWN Day One Biopharmaceuticals Inc 2022-09-21 10 percent owner
TYRA Tyra Biosciences Inc 2021-09-14 10 percent owner

Canaan Xi L.p. Latest Holdings Summary

Canaan Xi L.p. currently owns a total of 1 stock. Canaan Xi L.p. owns 6,964,301 shares of Day One Biopharmaceuticals Inc (DAWN) as of September 21, 2022, with a value of $109 Million.

Latest Holdings of Canaan Xi L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DAWN Day One Biopharmaceuticals Inc 2022-09-21 6,964,301 15.64 108,921,668

Holding Weightings of Canaan Xi L.p.


Canaan Xi L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Canaan Xi L.p. has made a total of 3 transactions in Day One Biopharmaceuticals Inc (DAWN) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Day One Biopharmaceuticals Inc is the sale of 613,603 shares on September 21, 2022, which brought Canaan Xi L.p. around $11 Million.

Insider Trading History of Canaan Xi L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Canaan Xi L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Canaan Xi L.p. Ownership Network

Ownership Network List of Canaan Xi L.p.

No Data

Ownership Network Relation of Canaan Xi L.p.

Insider Network Chart

Canaan Xi L.p. Owned Company Details

What does Day One Biopharmaceuticals Inc do?

Who are the key executives at Day One Biopharmaceuticals Inc?

Canaan Xi L.p. is the 10 percent owner of Day One Biopharmaceuticals Inc. Other key executives at Day One Biopharmaceuticals Inc include Chief Medical Officer Samuel C. Blackman , COO & CFO and Secretary York Charles N Ii , and director & Chief Executive Officer Jeremy Bender .

Day One Biopharmaceuticals Inc (DAWN) Insider Trades Summary

Over the past 18 months, Canaan Xi L.p. made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 210,055 shares made by Samuel C. Blackman , a net sale of 114,587 shares made by Jeremy Bender , and a net sale of 71,268 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 88,748 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 88,748 shares. During the past 18 months, 420,920 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 2,244,684 shares were bought by its insiders, resulting in a net purchase of 1,823,764 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Day One Biopharmaceuticals Inc Insider Transactions

No Available Data

Canaan Xi L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Canaan Xi L.p.. You might contact Canaan Xi L.p. via mailing address: 2765 Sand Hill Rd, Menlo Park Ca 94025.